106 related articles for article (PubMed ID: 28762267)
21. Synthesis and characterization of theranostic poly(HPMA)-c(RGDyK)-DOTA-64Cu copolymer targeting tumor angiogenesis: tumor localization visualized by positron emission tomography.
Yuan J; Zhang H; Kaur H; Oupicky D; Peng F
Mol Imaging; 2013 May; 12(3):203-12. PubMed ID: 23490439
[TBL] [Abstract][Full Text] [Related]
22. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
Qin Z; Liu W; Li L; Guo L; Yao C; Li X
Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
24. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
[TBL] [Abstract][Full Text] [Related]
25. Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo.
Prill JM; Subr V; Pasquarelli N; Engler T; Hoffmeister A; Kochanek S; Ulbrich K; Kreppel F
PLoS One; 2014; 9(1):e82716. PubMed ID: 24475024
[TBL] [Abstract][Full Text] [Related]
26. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: impact of release rate on biodistribution.
Chytil P; Hoffmann S; Schindler L; Kostka L; Ulbrich K; Caysa H; Mueller T; Mäder K; Etrych T
J Control Release; 2013 Dec; 172(2):504-12. PubMed ID: 23697767
[TBL] [Abstract][Full Text] [Related]
27. New perspectives of HPMA-based copolymers derived by post-polymerization modification.
Nuhn L; Barz M; Zentel R
Macromol Biosci; 2014 May; 14(5):607-18. PubMed ID: 24644097
[TBL] [Abstract][Full Text] [Related]
28. One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles.
Jia Z; Wong L; Davis TP; Bulmus V
Biomacromolecules; 2008 Nov; 9(11):3106-13. PubMed ID: 18844406
[TBL] [Abstract][Full Text] [Related]
29. N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities.
Zheng ZB; Zhu G; Tak H; Joseph E; Eiseman JL; Creighton DJ
Bioconjug Chem; 2005; 16(3):598-607. PubMed ID: 15898727
[TBL] [Abstract][Full Text] [Related]
30. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release: synthesis and characterization of distribution and tumor accumulation in mice by noninvasive multispectral optical imaging.
Hoffmann S; Vystrčilová L; Ulbrich K; Etrych T; Caysa H; Mueller T; Mäder K
Biomacromolecules; 2012 Mar; 13(3):652-63. PubMed ID: 22263698
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester.
Jäger E; Jäger A; Chytil P; Etrych T; Ríhová B; Giacomelli FC; Stěpánek P; Ulbrich K
J Control Release; 2013 Jan; 165(2):153-61. PubMed ID: 23178950
[TBL] [Abstract][Full Text] [Related]
32. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
Zhou Z; Xu X; Li L; Huang Y
J Drug Target; 2015; 23(9):821-31. PubMed ID: 25830626
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
[TBL] [Abstract][Full Text] [Related]
34. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
35. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
36. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.
David A; Kopecková P; Kopecek J; Rubinstein A
Pharm Res; 2002 Aug; 19(8):1114-22. PubMed ID: 12240936
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and Imaging.
Chytil P; Koziolová E; Janoušková O; Kostka L; Ulbrich K; Etrych T
Macromol Biosci; 2015 Jun; 15(6):839-50. PubMed ID: 25731143
[TBL] [Abstract][Full Text] [Related]
38. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
Buckway B; Wang Y; Ray A; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
[TBL] [Abstract][Full Text] [Related]
39. Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers.
Gormley AJ; Larson N; Banisadr A; Robinson R; Frazier N; Ray A; Ghandehari H
J Control Release; 2013 Mar; 166(2):130-8. PubMed ID: 23262203
[TBL] [Abstract][Full Text] [Related]
40. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
